BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23178365)

  • 1. Cytogenetics: oncology nurses in advanced practice decipher del(13q14) and t(14:16).
    Jacobson S; Eggert J; Smith K; Rosenzweig T
    Clin J Oncol Nurs; 2012 Dec; 16(6):E221-5. PubMed ID: 23178365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer genetics nursing: impact of the double helix.
    Greco KE
    Oncol Nurs Forum; 2000 Oct; 27(9 Suppl):29-36. PubMed ID: 11058981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetics and gene analysis: implications for oncology nurses.
    Stolzfus PK; Rust D; Ried T
    Clin J Oncol Nurs; 2001; 5(5):201-6. PubMed ID: 11899766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of deletion of the long arm of chromosome 13 and translocation of immunoglobulin heavy chain gene by interphase fluorescence in situ hybridization in patients with multiple myeloma].
    Sun WL; Wu YJ; Li H; Wang X; Zhuang JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):485-90. PubMed ID: 18795626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
    Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
    Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].
    Chen LJ; Li JY; Zhu Y; Wang XW; Qiu HR; Yang RF; Xu W; Xu JR; Lu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):102-5. PubMed ID: 19199264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core competencies in cancer genetics for advanced practice oncology nurses.
    Calzone KA; Jenkins J; Masny A
    Oncol Nurs Forum; 2002 Oct; 29(9):1327-33. PubMed ID: 12370702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity in multiple myeloma.
    Magrangeas F; Lodé L; Wuilleme S; Minvielle S; Avet-Loiseau H
    Leukemia; 2005 Feb; 19(2):191-4. PubMed ID: 15538406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncology nursing: educating advanced practice nurses to provide culturally competent care.
    Yeo TP; Phillips J; Delengowski A; Griffiths M; Purnell L
    J Prof Nurs; 2011; 27(4):245-54. PubMed ID: 21767822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.
    Sagaster V; Ludwig H; Kaufmann H; Odelga V; Zojer N; Ackermann J; Küenburg E; Wieser R; Zielinski C; Drach J
    Leukemia; 2007 Jan; 21(1):164-8. PubMed ID: 17096015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
    Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
    Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic aberrations in Tunisian patients with multiple myeloma identified by cIg-FISH in fixed bone marrow cells.
    Gmidène A; Avet-Loiseau H; Sennana H; Ben Abdallah I; Khlif A; Meddeb B; Elloumi M; Saad A
    Cytogenet Genome Res; 2012; 136(1):44-9. PubMed ID: 22188899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the molecular changes in patients with multiple myeloma by fluorescence in situ hybridization].
    Yang RF; Li CM; Chen LJ; Qiu HR; Yang H; Liu P; Xu JR; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):567-70. PubMed ID: 20931539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicolor spectral karyotyping (SKY) and its application to the cytogenetic diagnosis of multiple myeloma].
    Cigudosa JC; Calasanz MJ; García Miranda JL
    Sangre (Barc); 1999 Aug; 44(4):301-4. PubMed ID: 10589283
    [No Abstract]   [Full Text] [Related]  

  • 17. An Atlas on genes and chromosomes in oncology and haematology.
    Huret JL; Senon S; Bernheim A; Dessen P
    Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):805-7. PubMed ID: 15672464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncology clinical trials nursing: developing competencies for the novice.
    Lubejko B; Good M; Weiss P; Schmieder L; Leos D; Daugherty P
    Clin J Oncol Nurs; 2011 Dec; 15(6):637-43. PubMed ID: 22119974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics in cancer prediction, screening, and counseling: Part II, The nurse's role in genetic counseling.
    Loescher LJ
    Oncol Nurs Forum; 1995 Mar; 22(2 Suppl):16-9. PubMed ID: 7784227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R
    Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.